October 2008

3D MRI sequence aids rupture-prone plaque detection ()
Economic crisis hits home ()
Senate probes TCT over fiscal ties to industry ()
Boston Scientific losses narrow in Q3; despite falling stent sales ()
Lehman Brothers crisis incites Boston Scientific stock sell-off ()
Boston Scientific sees losses narrow in Q3, despite falling stent sales ()
Maryland Court of Appeals to rule on imaging self-referral case ()
ACS: Mammograms are best way to spot breast cancer ()
DE-MRI of left atrial wall scarring predicts a-fib ablation success ()
NIH awards $11M for MRI center, protein analysis software development ()
New Missouri brain imaging center to research autism, Parkinson's ()
MRI may be used to improve accuracy of internal thermometer ()
Philips, Celsion ink ultrasound research deal for cancer treatment ()
Government probes FDA actions in Actavis recalls ()
HORIZONS AMI data will likely lead to wider bivalirudin usage in acute MI ()
HORIZONS AMI finds DES more effective, as safe as BMS at one year ()
Philips decision support software assists in FDG-PET scan interpretations ()
Physicians at the root of Medicaid cancer screening delinquency ()
Philips opens Brazilian manufacturing facility ()
Fujifilm wins single-source FFDM contract from Amerinet ()
Imaging economics may ultimately drive U.S. CCTA policy ()
Ashva debuts RADiON 2.0, adds 150 licenses ()
FDA OKs Boston Scientific Taxus Liberte after two-year delay ()
Breast MRI usage climbs 23% in 2008 ()
3D sequence aids rupture-prone plaque detection ()
Sentinelle Medical seals CE Mark approval ()
New MRI method detects left atrial wall scarring in patients with atrial fibrillation ()
CT scans change treatment plans in ER patients with suspected appendicitis ()
EMEA addresses radioisotope shortage; appeals to private industry ()
Medtronic, Bos Sci ordered to pay J&J about $1.2B for stent patents ()